KUALA LUMPUR: Mah Sing Group Bhd’s healthcare business unit, Mah Sing Healthcare Sdn Bhd, has clinched enough long-term glove orders to take up four production lines.
At the same time, two more new production lines have already been completed at Mah Sing’s highly automated factory in Kapar, Klang, ready to take on more incoming orders, the group said in a statement today.
Group chief executive officer Datuk Ho Hon Sang said six other production lines are also scheduled to commence operations in the third quarter of this year.
These 12 lines make up phase one of Mah Sing’s glove manufacturing business, which is expected to contribute positively to the group’s earnings for financial year 2021.
“The strong orders reflect the market’s confidence towards Mah Sing as a credible new glove manufacturer in producing quality gloves to meet pent-up demand globally.
“We will focus on expanding capacity at our glove factory to meet these secured orders, and so far, we are operationally on track,” he said.
The group is also planning to expand its glove business if the demand continues to outstrip supply.
On the property segment, the company’s founder and group managing director Tan Sri Leong Hoy Kum said Mah Sing is on track to meet its RM1.6 billion sales target for 2021.
The company recorded property sales of RM650.5 million in the first five months of 2021, and is planning several property launches in the second half of 2021. – Bernama